Antigen-specific T cells are a powerful tool for understanding human immunity and developing treatments and cures for our most prolific diseases. Luckily, they are more readily available to researchers than ever before. Not only have we devoted many resources over the past several years to developing an exclusive inventory of antigen-specific T cells for use…
We are headed to the American Association for Cancer Research’s 2019 annual meeting in Atlanta! We will be at the show from March 31 – April 3 in booth #4907 to answer your immunology research questions and highlight our latest immune cell developments. If you will be in Atlanta for AACR, save this list of…
Cancer Patients Give Blood Cells to Advance Treatment Studies Cancer patients are fighting back and helping advance the development of cutting edge cancer treatments by giving blood cells for laboratory medical research. Patients giving small amounts of white blood cells allow preclinical scientists to study the potential effectiveness and critical safety of innovative immune treatments.…
MART-1 (melanoma antigen recognized by T cells 1) is a “widely shared melanoma antigen recognized by the T lymphocytes of patients with established malignancy.” MART-1 is one of the oldest identified tumor antigens and is a protein found on normal melanocytes in the skin and retina. It is also found in most melanomas, cancers that…
Scientific studies directly or indirectly involving human immunity require an understanding of both sides of the complex system. Even the development of an adaptive antigen-specific cell-based therapy requires components of the innate immune system that work in concert with the adaptive cells. If you don’t work primarily in immunology, this post will give you a…
A recent paper published in Nature, A dual origin for blood vessels, describes experiments that trace the development of endothelial cells in mice. By targeting expression of a fluorescent protein to cells of the yolk sac, Plein et al. were able to show that endothelial cells lining blood vessels develop from two different embryonic cell…
Progenitor cells and CD34+ cells are often referred to interchangeably as stem cells. While this oversimplification is technically correct, there are many distinctions between the origins, functions, and uses of progenitor cells and CD34+ cells. What is the Difference Between Progenitor and CD34+ Cells? Despite their many similarities, the most significant difference between the two…
We have wrapped up another successful year at SLAS2019. Our Director of Business Development, Ponni Anand, and I just returned, feeling energized and optimistic about this coming year. We enjoyed exchanging ideas and learning about different methods and techniques with researchers and technologists from different parts of the world. For the third year in a…
Throughout their lives, many people will donate blood. Far fewer people, however, will donate bone marrow. For this reason, serious bone marrow donors are desperately needed. If you are considering donating bone marrow, you need to prepare yourself for this process. Keep reading to learn what you need to know. Know Everything You Can About…
If you missed the news in August, Astarte Biologics merged with Key Biologics to become the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. As part of the merger, we are now offering leukapheresis products directly to our customers for use in late-stage immunology research.…